Poland – Pharmaceutical products – Purchase and successive delivery of various medicines, oncology medicines and medical devices.

Opportunity description

1. The subject of the contract is the purchase and successive delivery of various medicines, oncology medicines and medical devices, specified in 9 parts, for the Fryderyk Chopin University Clinical Hospital in Rzeszów. 2. A detailed description of the subject of the contract and the Contracting Authority’s requirements are set out in the Price and Tender Forms – Annexes Nos. 1, 2 and 3 to the SWZ for the individual parts, which constitute an integral part of the SWZ. 3. The Contracting Authority requires that the offered subjects of the contract: 3.1. meet the requirements contained in the Price and Tender Forms. 3.2. in Parts Nos. 1, 2, 3 and 5, 6, 7, 8 and 9 – insofar as the subject of the contract comprises medicinal products – be medicinal products authorised for marketing in the territory of the Republic of Poland in accordance with the Act of 6 September 2001 – Pharmaceutical Law (Journal of Laws of 2026, item 612, as amended). The Contracting Authority does not permit the offering of medicinal products authorised for marketing pursuant to Article 4(1) and (2) of the Act of 6 September 2001 – Pharmaceutical Law (Journal of Laws of 2026, item 612, as amended). 3.3. in Part No. 4 and insofar as the subject of the contract in Parts Nos. 1 and 2 comprises vaporisers and other medical devices specified in Annex No. 2 to the SWZ, be medical devices in accordance with the Act of 7 April 2022 on medical devices (Journal of Laws of 2024, item 1620, as amended) and meet the requirements specified in that Act and in the applicable provisions of European Union law, particularly with regard to placing on the market and putting into service, classification, conformity assessment, packaging and labelling. 3.4. in the case of reimbursed medicinal products – meet the requirements specified in the Act of 12 May 2011 on the reimbursement of medicines, foodstuffs intended for particular nutritional uses and medical devices (Journal of Laws of 2026, item 253, as amended), insofar as applicable to the subject of the contract. The Contracting Authority reserves the right to require the Contractor, at every stage of the procedure, to present documents confirming compliance with the requirements specified in this point, in particular documents confirming authorisation of the offered medicinal products for marketing in the territory of the Republic of Poland and documents confirming the conformity of the offered medical devices with the requirements of the applicable provisions of law. Note to point 3.4: If it is determined that the chemical substance in the dosage and form indicated in the SWZ is included in the Announcement of the Minister of Health concerning the list of reimbursed medicines, foodstuffs intended for particular nutritional uses and medical devices – Annex B and/or C – current as at the tender submission date, and the offered medicinal product is not listed therein, the tender will be rejected. The tender will also be rejected if the price of the offered medicinal product is higher than the official price indicated in the Announcement of the Minister of Health concerning the list of reimbursed medicines, foodstuffs intended for particular nutritional uses and medical devices current as at the tender submission date, provided that the official price applies to the medicinal product concerned. 4. The scope of the contract covers the delivery of the subjects of the contract in the quantities specified in the Price and Tender Forms for a period of: - for Parts Nos. 1, 2, 3 and 4 – 24 months from the date of conclusion of the contract. - for Parts Nos. 5, 6, 7, 8 and 9 – 12 months from the date of conclusion of the contract. 5. TIME LIMIT FOR PERFORMANCE OF THE CONTRACT: 1. The subject of the contract with regard to Parts Nos. 1 to 4 will be performed in the form of successive deliveries for a period of 24 months from the date of conclusion of the contract. 2. The subject of the contract with regard to Parts Nos. 5 to 9 will be performed in the form of successive deliveries for a period of 12 months from the date of conclusion of the contract. 3. If, during the term of the contract, the subject of the contract has not been performed in full with regard to Parts Nos. 1 to 9, the Contracting Authority reserves the option to extend the term of the contract. The term of the contract will be changed by means of a written annex signed by the Parties. The Contracting Authority will inform the Contractor of its intention to extend the term of the contract before the expiry of the term for which it was concluded. 6. Deadline for submitting a request for clarification of the contents of the SWZ: 15.09.2026. 1. Sevofluranum liquid for preparation of inhalation vapour ml bottle Together with the lease of the equipment necessary to administer the medicinal product offered in Part No. 1. 2. A detailed description of the subject of the contract and the Contracting Authority’s requirements are set out in the Price and Tender Form – Annexes Nos. 1, 2 and 3 to the SWZ. 3. The scope of the contract covers the delivery of the subjects of the contract in the quantities specified in the Price and Tender Forms for a period of 24 months from the date of conclusion of the contract. 4. The Contracting Authority does not permit the submission of equivalent tenders. 5. The subject of the contract with regard to Part No. 1 will be performed in the form of successive deliveries for a period of 24 months from the date of conclusion of the contract. 6. If, during the term of the contract, the subject of the contract has not been performed in full with regard to Part No. 1, the Contracting Authority reserves the option to extend the term of the contract. The term of the contract will be changed by means of a written annex signed by the Parties. The Contracting Authority will inform the Contractor of its intention to extend the term of the contract before the expiry of the term for which it was concluded. 1. Desfluranum liquid for inhalation ml bottle Together with the lease of the equipment necessary to administer the medicinal product offered in Part No. 2. 2. A detailed description of the subject of the contract and the Contracting Authority’s requirements are set out in the Price and Tender Form – Annexes Nos. 1, 2 and 3 to the SWZ. 3. The scope of the contract covers the delivery of the subjects of the contract in the quantities specified in the Price and Tender Forms for a period of 24 months from the date of conclusion of the contract. 4. The Contracting Authority does not permit the submission of equivalent tenders. 5. The subject of the contract with regard to Part No. 2 will be performed in the form of successive deliveries for a period of 24 months from the date of conclusion of the contract. 6. If, during the term of the contract, the subject of the contract has not been performed in full with regard to Part No. 2, the Contracting Authority reserves the option to extend the term of the contract. The term of the contract will be changed by means of a written annex signed by the Parties. The Contracting Authority will inform the Contractor of its intention to extend the term of the contract before the expiry of the term for which it was concluded. 1. Oncology medicines: Ferri hydroxidum saccharum solution for injection and infusion 20 mg Fe 3+/ml amp. 2. A detailed description of the subject of the contract and the Contracting Authority’s requirements are set out in the Price and Tender Form – Annex No. 1 to the SWZ. 3. The scope of the contract covers the delivery of the subjects of the contract in the quantities specified in the Price and Tender Forms for a period of 24 months from the date of conclusion of the contract. 4. The Contracting Authority does not permit the submission of equivalent tenders. 5. The subject of the contract with regard to Part No. 3 will be performed in the form of successive deliveries for a period of 24 months from the date of conclusion of the contract. 6. If, during the term of the contract, the subject of the contract has not been performed in full with regard to Part No. 3, the Contracting Authority reserves the option to extend the term of the contract. The term of the contract will be changed by means of a written annex signed by the Parties. The Contracting Authority will inform the Contractor of its intention to extend the term of the contract before the expiry of the term for which it was concluded. 1. Eye drops; Eye ointment; Moisturising nasal spray; Moisturising eye drops; Isotonic seawater solution. 2. A detailed description of the subject of the contract and the Contracting Authority’s requirements are set out in the Price and Tender Form – Annex No. 1 to the SWZ. 3. The scope of the contract covers the delivery of the subjects of the contract in the quantities specified in the Price and Tender Forms for a period of 24 months from the date of conclusion of the contract. 4. The Contracting Authority does not permit the submission of equivalent tenders. 5. The subject of the contract with regard to Part No. 4 will be performed in the form of successive deliveries for a period of 24 months from the date of conclusion of the contract. 6. If, during the term of the contract, the subject of the contract has not been performed in full with regard to Part No. 4, the Contracting Authority reserves the option to extend the term of the contract. The term of the contract will be changed by means of a written annex signed by the Parties. The Contracting Authority will inform the Contractor of its intention to extend the term of the contract before the expiry of the term for which it was concluded. 1. Methotrexatum 2.5 mg; 10 mg tablets. 2. A detailed description of the subject of the contract and the Contracting Authority’s requirements are set out in the Price and Tender Form – Annex No. 1 to the SWZ. 3. The scope of the contract covers the delivery of the subjects of the contract in the quantities specified in the Price and Tender Forms for a period of 12 months from the date of conclusion of the contract. 4. The Contracting Authority does not permit the submission of equivalent tenders. 5. The subject of the contract with regard to Part No. 5 will be performed in the form of successive deliveries for a period of 12 months from the date of conclusion of the contract. 6. If, during the term of the contract, the subject of the contract has not been performed in full with regard to Part No. 5, the Contracting Authority reserves the option to extend the term of the contract. The term of the contract will be changed by means of a written annex signed by the Parties. The Contracting Authority will inform the Contractor of its intention to extend the term of the contract before the expiry of the term for which it was concluded. 1. Aprepitantum caps. (125 mg cap. + 80 mg cap.). 2. A detailed description of the subject of the contract and the Contracting Authority’s requirements are set out in the Price and Tender Form – Annex No. 1 to the SWZ. 3. The scope of the contract covers the delivery of the subjects of the contract in the quantities specified in the Price and Tender Forms for a period of 12 months from the date of conclusion of the contract. 4. The Contracting Authority does not permit the submission of equivalent tenders. 5. The subject of the contract with regard to Part No. 6 will be performed in the form of successive deliveries for a period of 12 months from the date of conclusion of the contract. 6. If, during the term of the contract, the subject of the contract has not been performed in full with regard to Part No. 6, the Contracting Authority reserves the option to extend the term of the contract. The term of the contract will be changed by means of a written annex signed by the Parties. The Contracting Authority will inform the Contractor of its intention to extend the term of the contract before the expiry of the term for which it was concluded. 1. Bicalutamidum 150 mg film-coated tablets. 2. A detailed description of the subject of the contract and the Contracting Authority’s requirements are set out in the Price and Tender Form – Annex No. 1 to the SWZ. 3. The scope of the contract covers the delivery of the subjects of the contract in the quantities specified in the Price and Tender Forms for a period of 12 months from the date of conclusion of the contract. 4. The Contracting Authority does not permit the submission of equivalent tenders. 5. The subject of the contract with regard to Part No. 7 will be performed in the form of successive deliveries for a period of 12 months from the date of conclusion of the contract. 6. If, during the term of the contract, the subject of the contract has not been performed in full with regard to Part No. 7, the Contracting Authority reserves the option to extend the term of the contract. The term of the contract will be changed by means of a written annex signed by the Parties. The Contracting Authority will inform the Contractor of its intention to extend the term of the contract before the expiry of the term for which it was concluded. 1. Mercaptopurinum 50 mg tablets. 2. A detailed description of the subject of the contract and the Contracting Authority’s requirements are set out in the Price and Tender Form – Annex No. 1 to the SWZ. 3. The scope of the contract covers the delivery of the subjects of the contract in the quantities specified in the Price and Tender Forms for a period of 12 months from the date of conclusion of the contract. 4. The Contracting Authority does not permit the submission of equivalent tenders. 5. The subject of the contract with regard to Part No. 8 will be performed in the form of successive deliveries for a period of 12 months from the date of conclusion of the contract. 6. If, during the term of the contract, the subject of the contract has not been performed in full with regard to Part No. 8, the Contracting Authority reserves the option to extend the term of the contract. The term of the contract will be changed by means of a written annex signed by the Parties. The Contracting Authority will inform the Contractor of its intention to extend the term of the contract before the expiry of the term for which it was concluded. 1. Roxadustatum 20 mg; 50 mg; 70 mg tablets. 2. A detailed description of the subject of the contract and the Contracting Authority’s requirements are set out in the Price and Tender Form – Annex No. 1 to the SWZ. 3. The scope of the contract covers the delivery of the subjects of the contract in the quantities specified in the Price and Tender Forms for a period of 12 months from the date of conclusion of the contract. 4. The Contracting Authority does not permit the submission of equivalent tenders. 5. The subject of the contract with regard to Part No. 9 will be performed in the form of successive deliveries for a period of 12 months from the date of conclusion of the contract. 6. If, during the term of the contract, the subject of the contract has not been performed in full with regard to Part No. 9, the Contracting Authority reserves the option to extend the term of the contract. The term of the contract will be changed by means of a written annex signed by the Parties. The Contracting Authority will inform the Contractor of its intention to extend the term of the contract before the expiry of the term for which it was concluded. Procedure: open. Review the original TED notice for the complete requirement, lots, amendments and attachments.